Torii Pharmaceutical Co., Ltd. (4551.T)
JPY 4300.0
(0.82%)
JPY 4300.0
(0.82%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 54.63 Billion JPY | 11.75% |
| 2022 | 48.89 Billion JPY | 4.06% |
| 2021 | 46.98 Billion JPY | 12.68% |
| 2020 | 41.69 Billion JPY | -3.02% |
| 2019 | 42.99 Billion JPY | -31.26% |
| 2018 | 62.55 Billion JPY | -2.47% |
| 2017 | 64.13 Billion JPY | 6.52% |
| 2016 | 60.2 Billion JPY | -3.48% |
| 2015 | 62.37 Billion JPY | 43.39% |
| 2014 | 43.5 Billion JPY | -25.14% |
| 2013 | 58.1 Billion JPY | 11.12% |
| 2012 | 52.29 Billion JPY | 7.34% |
| 2011 | 48.71 Billion JPY | 7.46% |
| 2010 | 45.33 Billion JPY | 6.88% |
| 2009 | 42.41 Billion JPY | 13.57% |
| 2008 | 37.34 Billion JPY | -8.56% |
| 2007 | 40.84 Billion JPY | 3.2% |
| 2006 | 39.57 Billion JPY | -2.24% |
| 2005 | 40.48 Billion JPY | -3.41% |
| 2004 | 41.91 Billion JPY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 15.02 Billion JPY | 1.12% |
| 2024 Q2 | 14.85 Billion JPY | 10.46% |
| 2024 Q1 | 13.45 Billion JPY | -13.25% |
| 2023 Q3 | 13.43 Billion JPY | -3.28% |
| 2023 FY | 54.63 Billion JPY | 11.75% |
| 2023 Q4 | 15.5 Billion JPY | 15.43% |
| 2023 Q2 | 13.88 Billion JPY | 17.59% |
| 2023 Q1 | 11.81 Billion JPY | -13.02% |
| 2022 Q3 | 12.21 Billion JPY | 0.58% |
| 2022 Q2 | 12.14 Billion JPY | 10.78% |
| 2022 FY | 48.89 Billion JPY | 4.06% |
| 2022 Q1 | 10.96 Billion JPY | -19.11% |
| 2022 Q4 | 13.57 Billion JPY | 11.18% |
| 2021 FY | 46.98 Billion JPY | 12.68% |
| 2021 Q4 | 13.55 Billion JPY | 14.04% |
| 2021 Q1 | 9.89 Billion JPY | -14.12% |
| 2021 Q2 | 11.65 Billion JPY | 17.75% |
| 2021 Q3 | 11.88 Billion JPY | 1.94% |
| 2020 Q4 | 11.52 Billion JPY | 11.75% |
| 2020 Q1 | 9.57 Billion JPY | -18.04% |
| 2020 Q2 | 10.28 Billion JPY | 7.47% |
| 2020 Q3 | 10.31 Billion JPY | 0.28% |
| 2020 FY | 41.69 Billion JPY | -3.02% |
| 2019 Q3 | 10.63 Billion JPY | -7.7% |
| 2019 Q4 | 11.67 Billion JPY | 9.79% |
| 2019 FY | 42.99 Billion JPY | -31.26% |
| 2019 Q1 | 9.16 Billion JPY | -46.13% |
| 2019 Q2 | 11.52 Billion JPY | 25.78% |
| 2018 Q3 | 14.99 Billion JPY | -9.8% |
| 2018 FY | 62.55 Billion JPY | -2.47% |
| 2018 Q1 | 13.93 Billion JPY | -24.33% |
| 2018 Q4 | 17 Billion JPY | 13.44% |
| 2018 Q2 | 16.62 Billion JPY | 19.32% |
| 2017 Q2 | 16.48 Billion JPY | 21.12% |
| 2017 FY | 64.13 Billion JPY | 6.52% |
| 2017 Q4 | 18.4 Billion JPY | 17.73% |
| 2017 Q3 | 15.63 Billion JPY | -5.13% |
| 2017 Q1 | 13.6 Billion JPY | -17.22% |
| 2016 Q2 | 15.27 Billion JPY | 11.16% |
| 2016 Q1 | 13.74 Billion JPY | -21.65% |
| 2016 FY | 60.2 Billion JPY | -3.48% |
| 2016 Q4 | 16.43 Billion JPY | 11.41% |
| 2016 Q3 | 14.75 Billion JPY | -3.39% |
| 2015 FY | 62.37 Billion JPY | 43.39% |
| 2015 Q4 | 17.53 Billion JPY | 13.82% |
| 2015 Q3 | 15.4 Billion JPY | -4.52% |
| 2015 Q2 | 16.13 Billion JPY | 21.34% |
| 2015 Q1 | 13.29 Billion JPY | 0.0% |
| 2014 Q3 | 14.5 Billion JPY | 17.37% |
| 2014 Q1 | 14.58 Billion JPY | -6.91% |
| 2014 FY | 43.5 Billion JPY | -25.14% |
| 2014 Q2 | 12.35 Billion JPY | -15.28% |
| 2013 Q4 | 15.66 Billion JPY | 12.62% |
| 2013 FY | 58.1 Billion JPY | 11.12% |
| 2013 Q1 | 11.76 Billion JPY | -18.12% |
| 2013 Q2 | 13.94 Billion JPY | 18.55% |
| 2013 Q3 | 13.91 Billion JPY | -0.26% |
| 2012 Q4 | 14.36 Billion JPY | 11.28% |
| 2012 FY | 52.29 Billion JPY | 7.34% |
| 2012 Q1 | 11.08 Billion JPY | -18.56% |
| 2012 Q2 | 13.24 Billion JPY | 19.52% |
| 2012 Q3 | 12.91 Billion JPY | -2.52% |
| 2011 FY | 48.71 Billion JPY | 7.46% |
| 2011 Q2 | 11.77 Billion JPY | 8.41% |
| 2011 Q3 | 12.24 Billion JPY | 4.02% |
| 2011 Q4 | 13.6 Billion JPY | 11.09% |
| 2011 Q1 | 10.86 Billion JPY | -9.72% |
| 2010 Q2 | 11.37 Billion JPY | 21.78% |
| 2010 FY | 45.33 Billion JPY | 6.88% |
| 2010 Q4 | 12.03 Billion JPY | 8.75% |
| 2010 Q3 | 11.06 Billion JPY | -2.77% |
| 2010 Q1 | 9.34 Billion JPY | -19.48% |
| 2009 Q1 | 8.29 Billion JPY | -19.37% |
| 2009 Q2 | 10.74 Billion JPY | 29.56% |
| 2009 Q3 | 10.72 Billion JPY | -0.26% |
| 2009 Q4 | 11.6 Billion JPY | 8.25% |
| 2009 FY | 42.41 Billion JPY | 13.57% |
| 2008 Q4 | 10.28 Billion JPY | 10.84% |
| 2008 Q3 | 9.28 Billion JPY | 0.0% |
| 2008 FY | 37.34 Billion JPY | -8.56% |
| 2007 FY | 40.84 Billion JPY | 3.2% |
| 2006 FY | 39.57 Billion JPY | -2.24% |
| 2005 FY | 40.48 Billion JPY | -3.41% |
| 2004 FY | 41.91 Billion JPY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 62.14 Billion JPY | 12.083% |
| Takeda Pharmaceutical Company Limited | 4263.76 Billion JPY | 98.719% |
| Sumitomo Pharma Co., Ltd. | 314.55 Billion JPY | 82.63% |
| Shionogi & Co., Ltd. | 435.08 Billion JPY | 87.442% |
| Wakamoto Pharmaceutical Co.,Ltd. | 7.73 Billion JPY | -606.061% |
| Nippon Shinyaku Co., Ltd. | 148.25 Billion JPY | 63.146% |
| Kaken Pharmaceutical Co., Ltd. | 72.04 Billion JPY | 24.16% |
| Eisai Co., Ltd. | 741.75 Billion JPY | 92.634% |
| Morishita Jintan Co., Ltd. | 12.4 Billion JPY | -340.416% |
| Hisamitsu Pharmaceutical Co., Inc. | 141.7 Billion JPY | 61.443% |
| Mochida Pharmaceutical Co., Ltd. | 102.88 Billion JPY | 46.894% |
| Fuso Pharmaceutical Industries,Ltd. | 55.4 Billion JPY | 1.386% |
| Nippon Chemiphar Co., Ltd. | 30.74 Billion JPY | -77.696% |
| Tsumura & Co. | 150.84 Billion JPY | 63.779% |
| Kissei Pharmaceutical Co., Ltd. | 75.57 Billion JPY | 27.707% |
| Towa Pharmaceutical Co., Ltd. | 227.93 Billion JPY | 76.029% |
| Fuji Pharma Co., Ltd. | 40.88 Billion JPY | -33.625% |
| Zeria Pharmaceutical Co., Ltd. | 75.72 Billion JPY | 27.847% |
| KYORIN Holdings, Inc. | 119.53 Billion JPY | 54.29% |
| Taiko Pharmaceutical Co.,Ltd. | 5.04 Billion JPY | -984.087% |
| Daito Pharmaceutical Co.,Ltd. | 46.89 Billion JPY | -16.511% |
| SymBio Pharmaceuticals Limited | 5.58 Billion JPY | -877.475% |
| MedRx Co., Ltd | 26 Million JPY | -210046.154% |
| Mizuho Medy Co.,Ltd. | 10.98 Billion JPY | -397.173% |
| Solasia Pharma K.K. | 617 Million JPY | -8755.429% |
| Modalis Therapeutics Corporation | - JPY | -Infinity% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 62.84 Billion JPY | 13.056% |
| Sawai Group Holdings Co., Ltd. | 176.86 Billion JPY | 69.107% |
| Cyfuse Biomedical K.K. | 61.11 Million JPY | -89306.336% |
| Toho Holdings Co., Ltd. | 1476.71 Billion JPY | 96.3% |
| Koa Shoji Holdings Co.,Ltd. | 22.13 Billion JPY | -146.849% |